0000950170-23-071107.txt : 20231218
0000950170-23-071107.hdr.sgml : 20231218
20231218163018
ACCESSION NUMBER: 0000950170-23-071107
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231214
FILED AS OF DATE: 20231218
DATE AS OF CHANGE: 20231218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALTSCHULLER Susan
CENTRAL INDEX KEY: 0001817988
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41837
FILM NUMBER: 231494157
MAIL ADDRESS:
STREET 1: 45 TENNYSON ST.
CITY: SOMERVILLE
STATE: MA
ZIP: 02145
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mural Oncology plc
CENTRAL INDEX KEY: 0001971543
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 EARLSFORT TERRACE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 T380
BUSINESS PHONE: 353 1 905 8020
MAIL ADDRESS:
STREET 1: 10 EARLSFORT TERRACE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 T380
FORMER COMPANY:
FORMER CONFORMED NAME: Mural Oncology Ltd
DATE OF NAME CHANGE: 20230403
FORMER COMPANY:
FORMER CONFORMED NAME: Pistachiovale Ltd
DATE OF NAME CHANGE: 20230329
4
1
ownership.xml
4
X0508
4
2023-12-14
0001971543
Mural Oncology plc
MURA
0001817988
ALTSCHULLER Susan
C/O MURAL ONCOLOGY PLC
10 EARLSFORT TERRACE
DUBLIN 2
L2
D02 T380
IRELAND
true
false
false
false
false
Stock Option (right to buy)
3.61
2023-12-14
4
A
false
15021
0.00
A
2033-12-13
Ordinary Shares
15021
15021
D
This option was granted on December 14, 2023. This option shall vest over three years in twelve equal quarterly installments on each quarterly anniversary of October 31, 2023, subject to the reporting person's continued service with the Issuer.
/s/ Maiken Keson-Brookes, attorney-in-fact for Susan Altschuller
2023-12-18